| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |